Related Experiment Video
Updated: Nov 15, 2025

Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
Published on: November 9, 2016
Botulinum Neurotoxin Injections in Childhood Opisthotonus
Mariam Hull1,2, Mered Parnes1,2, Joseph Jankovic2
1Section of Pediatric Neurology and Developmental Neuroscience, Texas Children's Hospital and Baylor College of Medicine, Houston, TX 77030, USA.
Insights
Botulinum neurotoxin injections effectively relieved painful opisthotonus symptoms in children. This treatment offers a promising option for managing this challenging pediatric condition affecting trunk posture and quality of life.
Area of Science:
- Neurology
- Pediatrics
- Physical Medicine & Rehabilitation
Background:
- Opisthotonus is characterized by abnormal trunk extension due to paraspinal muscle overactivity.
- In children, it is frequently linked to dystonia from hypoxic injury or genetic/acquired causes.
- This condition causes pain, impairs mobility, and reduces quality of life, with limited systematic reviews on pediatric management.
Purpose of the Study:
- To evaluate the efficacy of botulinum neurotoxin injections in treating pediatric opisthotonus.
- To describe symptom relief in a series of children managed with this therapeutic approach.
Main Methods:
- A case series of seven pediatric patients with opisthotonus was reviewed.
- Botulinum neurotoxin injections were administered to manage symptoms.
Main Results:
- All seven children experienced symptom relief following botulinum neurotoxin administration.
- This suggests a positive therapeutic response to the intervention.
Conclusions:
- Botulinum neurotoxin injections represent a viable and effective treatment for pediatric opisthotonus.
- Further systematic reviews are warranted to establish optimal management strategies for this condition in children.
Abstract:
Opisthotonus refers to abnormal axial extension and arching of the trunk produced by excessive contractions of the paraspinal muscles. In childhood, the abnormal posture is most often related to dystonia in the setting of hypoxic injury or a number of other acquired and genetic etiologies. The condition is often painful, interferes with ambulation and quality of life, and is challenging to treat. Therapeutic options include oral benzodiazepines, oral and intrathecal baclofen, botulinum neurotoxin injections, and deep brain stimulation. Management of opisthotonus within the pediatric population has not been systematically reviewed. Here, we describe a series of seven children who presented to our institution with opisthotonus in whom symptom relief was achieved following administration of botulinum neurotoxin injections.
More Related Videos
12:25Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
Published on: March 3, 2014
10:30A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
Published on: December 27, 2013
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...